Löffler J, Langui D, Probst A, Huber G
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Neurochem Int. 1994 Mar;24(3):281-8. doi: 10.1016/0197-0186(94)90086-8.
Proteolytic processing of beta-amyloid precursor protein (beta-APP) is a key event in the formation of beta-amyloid deposits in Alzheimer's disease (AD) brains and is likely to be accompanied by the accumulation of cleavage products other than the beta/A4 protein. Using a beta-APP695-specific monoclonal antibody in quantitative immunoblotting, a 50 kDa N-terminal fragment of beta-APP695 was detected in neocortex, hippocampus and cerebellum of AD patients and control individuals. The mean level of this fragment was higher in AD hippocampus and neocortex as compared to controls, suggesting that beta-APP695 fragments are generated in various brain regions but that the proteolytic processing is increased in pathologically affected brain areas.
β-淀粉样前体蛋白(β-APP)的蛋白水解加工是阿尔茨海默病(AD)患者大脑中β-淀粉样蛋白沉积形成过程中的关键事件,并且可能伴随着β/A4蛋白以外的裂解产物的积累。在定量免疫印迹中使用β-APP695特异性单克隆抗体,在AD患者和对照个体的新皮质、海马体和小脑中检测到β-APP695的一个50 kDa N端片段。与对照组相比,该片段在AD海马体和新皮质中的平均水平更高,这表明β-APP695片段在不同脑区产生,但在病理受影响的脑区蛋白水解加工增加。